2141 - 2150 of 6284 Results
Title
Year
-
OPENTitle: Olfactory impairment in Wilson’s diseaseJournal Name: Brain and BehaviorPublisher: WileyVol: 11Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/brb3.2022Best OA location URL: https://doi.org/10.1002/brb3.2022Citation Count: 14
- Modelling item scores of Unified Parkinson's Disease Rating Scale Part III for greater trial efficiency2021OPENTitle: Modelling item scores of Unified Parkinson's Disease Rating Scale Part III for greater trial efficiencyJournal Name: British Journal of Clinical PharmacologyPublisher: WileyVol: 87Issue #: 9Start Page: 3608End Page: 3618Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/bcp.14777Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bcp.14777Citation Count: 15
- Characterizing resting‐state networks in Parkinson’s disease: A multi‐aspect functional connectivity study2021OPENTitle: Characterizing resting‐state networks in Parkinson’s disease: A multi‐aspect functional connectivity studyJournal Name: Brain and BehaviorPublisher: WileyVol: 11Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/brb3.2101Best OA location URL: https://doi.org/10.1002/brb3.2101Citation Count: 13
- A Disease Progression Model to Quantify the Nonmotor Symptoms of Parkinson’s Disease in Participants With Leucine‐Rich Repeat Kinase 2 Mutation2021OPENTitle: A Disease Progression Model to Quantify the Nonmotor Symptoms of Parkinson’s Disease in Participants With Leucine‐Rich Repeat Kinase 2 MutationJournal Name: Clinical Pharmacology & TherapeuticsPublisher: WileyVol: 110Issue #: 2Start Page: 508End Page: 518Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/cpt.2277Citation Count: 13
- Pharmacogenetic Predictors of Cannabidiol Response and Tolerability in Treatment‐Resistant Epilepsy2021OPENTitle: Pharmacogenetic Predictors of Cannabidiol Response and Tolerability in Treatment‐Resistant EpilepsyJournal Name: Clinical Pharmacology & TherapeuticsPublisher: WileyVol: 110Issue #: 5Start Page: 1368End Page: 1380Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/cpt.2408Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.2408Citation Count: 31
- Integrative functional genomic analysis of intron retention in human and mouse brain with Alzheimer's disease2021OPENTitle: Integrative functional genomic analysis of intron retention in human and mouse brain with Alzheimer's diseaseJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 17Issue #: 6Start Page: 984End Page: 1004Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/alz.12254Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.12254Citation Count: 37
-
OPENTitle: Alzheimer's disease alters oligodendrocytic glycolytic and ketolytic gene expressionJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 17Issue #: 9Start Page: 1474End Page: 1486Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/alz.12310Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.12310Citation Count: 52
- Genetic risk, adherence to a healthy lifestyle, and cognitive decline in African Americans and European Americans2021OPENTitle: Genetic risk, adherence to a healthy lifestyle, and cognitive decline in African Americans and European AmericansJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 18Issue #: 4Start Page: 572End Page: 580Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.12435Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8789942Citation Count: 28
-
OPENTitle: Impact of increased APP gene dose in Down syndrome and the Dp16 mouse modelJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 18Issue #: 6Start Page: 1203End Page: 1234Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.12463Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9085977Citation Count: 44
- Soluble P‐tau217 reflects both amyloid and tau pathology in the human brain and mediates the association of amyloid with neocortical tau2021OPENTitle: Soluble P‐tau217 reflects both amyloid and tau pathology in the human brain and mediates the association of amyloid with neocortical tauJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 17Issue #: S5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.050391Citation Count: 0